End Cash: The amount of cash held by the company for the given period.
Quest Diagnostics Incorporated (DGX) had End Cash of $474.00M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$2.37B |
|
$194.00M |
|
$1.59B |
|
$771.00M |
|
$2.07B |
|
$300.00M |
|
$-34.00M |
|
$266.00M |
|
$266.00M |
|
$200.00M |
|
$208.00M |
|
$208.00M |
|
$200.00M |
|
$300.00M |
|
$416.00M |
|
111.00M |
|
112.00M |
|
$1.74 |
|
$1.72 |
|
| Balance Sheet Financials | |
$2.23B |
|
$1.81B |
|
$11.73B |
|
$13.95B |
|
$2.30B |
|
$3.80B |
|
$5.19B |
|
$7.49B |
|
$6.47B |
|
$-2.55B |
|
$6.47B |
|
111.00M |
|
| Cash Flow Statement Financials | |
$154.00M |
|
$-213.00M |
|
$-153.00M |
|
$686.00M |
|
|
End Cash |
$474.00M |
$-212.00M |
|
$22.00M |
|
$-79.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.97 |
|
-- |
|
-- |
|
0.37 |
|
0.73 |
|
32.59% |
|
12.68% |
|
12.68% |
|
-- |
|
11.24% |
|
8.20% |
|
$50.00M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
8.81 |
|
1.79 |
|
50.29 |
|
3.22% |
|
-8.15% |
|
1.49% |
|
2.02% |
|
$58.28 |
|
$0.45 |
|
$1.38 |
|